Our data, obtained using established cell lines, patient tumor samples, and primary GBM lines, depict a complex scenario where IRE1 signaling orchestrates distinct aspects of GBM biology, thereby offering novel targets for therapeutic intervention. Here, ERN1 is linked to neoplasm.